1. Acute Pulmonary Exacerbations of Sarcoidosis
Efstratios Panselinas, MD, Marc A. Judson, MD, FCCP 
CHEST 
Volume 142, Issue 4, Pages (October 2012)
DOI: /chest
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

2. Figure 1
The duration of therapy could determine the chance of relapse because sarcoidosis treatment may not affect the natural course of disease. If the duration of therapy exceeds the duration of disease activity (Therapy A), then the patient will not relapse when therapy is withdrawn. If the duration of therapy is shorter than the duration of disease activity (Therapy B), then the patient will relapse when therapy is withdrawn. (Reproduced with permission from Judson.54)
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

3. Figure 2
A proposed treatment algorithm for APES (see “Therapy for APES” section). APES = acute pulmonary exacerbations of sarcoidosis.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions